Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Lupilan

Approved

STANDARD

Lupilan

Jubilant Generics Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 73e4b7a5c73cff74
Company: Jubilant Generics Limited
Type: Standard

Approval Details

Approval Id: 73e4b7a5c73cff74
Drug Approval Philippines Name: Lupilan
Product Name: Lupilan
Registration Number: DRP-5586
Brand Name: Lupilan
Generic Name: Olanzapine
Dosage Form: Orodispersible Tablet
Dosage Strength: 10 mg
Manufacturer: Jubilant Generics Limited
Importer: MedEthix, Inc.
Distributor: Multicare Pharmaceutical Phils.
Company Detail Path: /organization/jubilant-generics-limited
Issuance Date: 24 January 2022
Expiry Date: 28 March 2027
Pharmacologic Category: Antipsychotics
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

73e4b7a5c73cff74

Type

Standard

Back to Philippines FDA Approvals

Lupilan - Philippines FDA Drug Approval Details